Background: Globally, dengue, a mosquito-borne viral infection, is the most rapidly spreading vector-borne disease. Dengue fever is endemic in >100 countries including India. Dengue has a variety of clinical presentations. The objective of the study was to understand the clinical features, laboratory profile and outcomes of dengue fever among patients admitted in a tertiary care hospital in Delhi, National Capital Region.Methods: This was a cross-sectional study among 75 dengue confirmed (NS-1 antigen and/or IgM antibody positive) patients with fever <1 week. The variables included were socio-demographic; clinical features; laboratory and radiological profile and outcomes. Descriptive analysis was used.Results: The majority of the patients were aged between 18-40 years 72% and predominantly males 68%. A total of 18.7% patients (malaria: 13.3% and chikungunya: 5.3%) had co-infection. Fever was present in all the patients, followed by myalgia (74.7% patients), retro-orbital pain/headache 69.3%, and vomiting 45.3%. The mean hemoglobin was 13.9 gm/dl, leukopenia 46.7% patients, thrombocytopenia 96.0% and elevated liver enzymes 69.3%. Radiological examination showed pleural effusion 6.7%, gallbladder wall thickening 6.7%, splenomegaly 4.0%, and hepatomegaly 2.7%. The outcomes included ICU care 17.3%, ventilator support 13.3%, blood transfusion 14.7%, and mortality 1.3% during the hospital stay.Conclusions: Dengue has become a major public health problem in India. The most common clinical features are fever, myalgia, headache and vomiting; laboratory abnormalities are leukopenia, thrombocytopenia and deranged liver enzymes. No specific treatment exists, but early detection and proper medical care lowers fatality rates.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.